Non-nucleoside reverse transcriptase inhibitors

Details for Australian Patent Application No. 2007334598 (hide)

Owner Merck & Co., Inc.

Inventors Jolly, Samson M.; Gomez, Robert; Anthony, Neville J.; Lim, John; Su, Dai-Shi

Agent Spruson & Ferguson

Pub. Number AU-A-2007334598

PCT Pub. Number WO2008/076225

Priority 60/874,629 13.12.06 US

Filing date 6 December 2007

Wipo publication date 26 June 2008

International Classifications

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/437 (2006.01)

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 249/18 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/076225 Priority application(s): WO2008/076225

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. Amendments

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007334600-Method and apparatus for generating nitric oxide for medical use

2007334555-Facet joint prosthesis